Physician profile
Mark Defrancisco
NPI 1588605729
$4,479.28
in general payments reported to CMS, 2019-2025
14 companies · $777 in 2025
The $777 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,070 · 2020: $129 · 2021: $83.55 · 2022: $207 · 2023: $642 · 2024: $570 · 2025: $777.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,989.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,988.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $1,736.12 | 2019 | |
| W. L. Gore & Associates, INC. | $829.29 | 2020-2025 | Gore Excluder Iliac Branch Endoprosthesis, Gore Viabahn Vbx Balloon Expandable Endo, Excluder Conformable Aaa Endoprosthesis With Active Control |
| Endologix LLC | $741.89 | 2019-2025 | Torus Stent Graft System, Endocross Device |
| Medtronic, INC. | $288.50 | 2021-2024 | Endurant Iis |
| Shockwave Medical, INC | $246.14 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Lemaitre Vascular, INC. | $171.54 | 2021-2023 | Restoreflow |
| Inari Medical, INC. | $138.86 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Abbott Laboratories | $130.01 | 2019 | |
| Boston Scientific Corporation | $84.56 | 2020-2021 | |
| Cardiovascular Systems INC. | $40.11 | 2019 | |
| Cook Medical LLC | $24.37 | 2020 | |
| Glaxosmithkline, LLC. | $18.13 | 2023 | Shingrix |
| Medtronic Vascular, INC. | $17.00 | 2019 | |
| Bard Peripheral Vascular, INC. | $12.76 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Defrancisco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.